Robotic approach for partial adrenalectomy

Calì, Benedetto; Nomine-Criqui, Claire; Bihain, Florence; Brunaud, Laurent

doi:10.1007/s13304-020-00957-6

Cited by 4 publications

(3 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Endorsement of robotic technologies and fluorescence techniques in adrenal surgery, may further improve PA results and consequently avoid unnecessary TA [ 44 ]. Indeed, one of the advantages of the robotic approach in PA consists of reducing gland manipulation, thus preserving the vascularization of the residual adrenal tissue and overcoming some limitations of the conventional laparoscopic approach [ 44 ].…”

Section: Discussionmentioning

confidence: 99%

“…It seems that, when the remnant of the adrenal gland is left in situ, without excessive and unnecessary mobilization, there are sufficient collateral arteries and veins providing vascular supply [ 20 ]. Use of ICG has been described as a useful technique to subjectively note the perfusion of the remnant adrenal gland following resection [ 2 , 44 ]. Exhibition of fluorescence is dependent on the histological tissue features (medullary vs. cortical).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Outcome of Partial Adrenalectomy in MEN2 Syndrome: Personal Experience and Systematic Review of Literature

Procopio

Pennestrì

Crea

et al. 2023

Life

View full text Add to dashboard Cite

Background: Partial adrenalectomy (PA) is an alternative option to total adrenalectomy for the treatment of hereditary pheochromocytoma (PHEO) to preserve cortical function and avoid life-long steroid replacement. The aim of this review is to summarize current evidence in terms of clinical outcome, recurrence, and corticosteroid therapy implementation after PA for MEN2-PHEOs. Material and Methods: From a total of 931 adrenalectomies (1997–2022), 16 of the 194 patients who underwent surgical treatment of PHEO had MEN2 syndrome. There were six patients scheduled for PA. MEDLINE®, EMBASE®, Web of Science, and Cochrane Library were searched for English studies from 1981 to 2022. Results: Among six patients who underwent PA for MEN2-related PHEO in our center, we reported two with bilateral synchronous disease and three with metachronous PHEOs. One recurrence was registered. Less than 20 mg/day Hydrocortison therapy was necessary in 50% of patients after bilateral procedures. Systematic review identified 83 PA for MEN2-PHEO. Bilateral synchronous PHEO, metachronous PHEO and disease recurrence were reported in 42%, 26%, and 4% of patients, respectively. Postoperative steroid implementation was necessary in 65% of patients who underwent bilateral procedures. Conclusions: PA seems to be a safe and valuable option for the treatment of MEN2-related PHEOs, balancing the risk of disease recurrence with the need for corticosteroid therapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Outcome of Partial Adrenalectomy in MEN2 Syndrome: Personal Experience and Systematic Review of Literature

Procopio

Pennestrì

Crea

et al. 2023

Life

View full text Add to dashboard Cite

show abstract

“…Endorsement of robotic technologies may extend indications of PA, in analogy with partial nephrectomy in renal tumors (3). Recent studies illustrated that robot-assisted partial adrenalectomy (RAPA) promises encouraging perioperative and functional outcomes in small benign and hormonal active adrenal tumors (4)(5)(6). However, the most frequently used DaVinci ® robot (Intuitive Surgical, Sunnyvale, CA, USA) for RAPA was challenged by its longer operative time and remarkably higher costs especially for patients in developing countries (7,8).…”

Section: Introductionmentioning

confidence: 99%

Feasibility, safety and effectiveness of robot-assisted retroperitoneal partial adrenalectomy with a new robotic surgical system: A prospective clinical study

Dong

Liu

et al. 2023

Front. Surg.

View full text Add to dashboard Cite

ObjectivesTo evaluate the feasibility, safety and efficacy of the newly developed KD-SR-01® robotic system for retroperitoneal partial adrenalectomy.Subjects and MethodsWe prospectively enrolled patients with benign adrenal mass undergoing KD-SR-01® robot-assisted partial adrenalectomy in our institution from November 2020 to May 2022. Surgeries were performed via a retroperitoneal approach using the KD-SR-01® robotic system. The baseline, perioperative and short-term follow-up data were prospectively collected. A descriptive statistical analysis was performed.ResultsA total of 23 patients were enrolled, including nine (39.1%) patients with hormone-active tumors. All patients received partial adrenalectomy via the retroperitoneal approach without conversions to other procedures. The median operative time was 86.5 min [interquartile range (IQR), 60.0–112.5] and the median estimated blood loss was 50 ml (range, 20–400). Three (13.0%) patients developed Clavien-Dindo grade I-II postoperative complications. The median postoperative stay was 4.0 days (IQR, 3.0–5.0). All surgical margins were negative. The short-term follow-up demonstrated complete or partial clinical and biochemical success as well as absence of imaging recurrence in all patients with hormone-active tumors.ConclusionsInitial results illustrate that the KD-SR-01® robotic system is safe, feasible and effective for the surgical management of benign adrenal tumors.

show abstract

Robotic Left Partial Adrenalectomy in Multiple Endocrine Neoplasia Type 2A and Previous Total Right Adrenalectomy

Coratti,

Perigli,

Parenti

et al. 2023

VideoEndocrinology™

View full text Add to dashboard Cite

Robotic approach for partial adrenalectomy

Cited by 4 publications

References 38 publications

Outcome of Partial Adrenalectomy in MEN2 Syndrome: Personal Experience and Systematic Review of Literature

Outcome of Partial Adrenalectomy in MEN2 Syndrome: Personal Experience and Systematic Review of Literature

Feasibility, safety and effectiveness of robot-assisted retroperitoneal partial adrenalectomy with a new robotic surgical system: A prospective clinical study

Robotic Left Partial Adrenalectomy in Multiple Endocrine Neoplasia Type 2A and Previous Total Right Adrenalectomy

Contact Info

Product

Resources

About